# C_2008033EN.01001101.xml

| 7.2.2008 | EN | Official Journal of the European Union | C 33/11 |
| --- | --- | --- | --- |

7.2.2008

EN

Official Journal of the European Union

C 33/11

---

Prior notification of a concentration

(Case COMP/M.5033 — Philips/Respironics)

(Text with EEA relevance)

(2008/C 33/09)

| 1. | On 30 January 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Koninklijke Philips Electronics NV (‘Philips’, the Netherlands) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Respironics Inc. (‘Respironics’, USA) by way of public bid announced on 21 December 2007. |
| --- | --- |

1.

On 30 January 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Koninklijke Philips Electronics NV (‘Philips’, the Netherlands) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Respironics Inc. (‘Respironics’, USA) by way of public bid announced on 21 December 2007.

1

| 2. | The business activities of the undertakings concerned are:






  — | for undertaking Philips: a multinational company active in the research, development, manufacture and sale of a wide range of electronic products, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for undertaking Philips: a multinational company active in the research, development, manufacture and sale of a wide range of electronic products,

| — | for undertaking Respironics: develops, manufactures and distributes medical devices used primarily for the treatment of patients suffering from sleep and respiratory disorders. |
| --- | --- |

—

for undertaking Respironics: develops, manufactures and distributes medical devices used primarily for the treatment of patients suffering from sleep and respiratory disorders.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5033 — Philips/Respironics, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5033 — Philips/Respironics, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---